In addition, significant downregulation of SOCS6 was observed in GC tissues (Figure 5B), and high expression levels of SOCS6 were associated with better prognosis (HR = 0.53, 95% CI = 0.43-0.64), even in patients with advanced TNM stages (Supplementary Figure 2). This evidence concerns the gene SOCS6 and gastric cancer.